Sort
16,300 grants matching “fatty liver disease”
Investigating Synthetic Ligands for the Treatment of NASH
$56,042Kristine Griffett · Saint Louis University · F32 · FY2015 · DK
FGF21 activates HPA and sympathetics via neuroinflammation and plasticity
$56,042Amy Elizabeth Bruestle Packard · University Of Cincinnati · F32 · FY2015 · DK
The retinoid burst in hepatic stellate cell mediated liver fibrosis
$56,042Loretta L. Jophlin · Medical University Of South Carolina · F32 · FY2015 · DK
Epigenetic modulation of metabolism and development by TOR complex 2
$56,042Christopher M Webster · Massachusetts General Hospital · F32 · FY2015 · DK
The role of alpha-cell mitochondria in glucagon secretion and glucose homeostasis
$56,042Jennifer Helene Stern · Ut Southwestern Medical Center · F32 · FY2015 · DK
Role of miR-33b in the differentiation and function of white adipose tissue
$55,982Nathan Price · Yale University · F32 · FY2014 · DK
Long Term Implications of Preeclampsia: Role of Obesity vs sFlt-1 Overexpression
$55,837Egle Bytautiene Prewit · University Of Texas Med Br Galveston · R03 · FY2009 · HD
Regulation of Hepatic Glucose Homeostasis by Phosphatidylcholine Transfer Protein
$55,826Baran Ersoy · Brigham And Women'S Hospital · F32 · FY2011 · DK
Regulation of PTEN in chronic alcohol mediated liver disease
$55,790Colin Shearn · University Of Colorado Denver · F32 · FY2010 · AA
The Role of IL-6 in the Pathogenesis of Alcoholic Steatosis
$55,778Margaret S Sozio · Indiana University Indianapolis · F32 · FY2008 · AA
Nested Study: Identifying Risk for Diabetes and Heart Disease in Women: A Study of African-American, African and White Federal Employees and Contractors
$55,761Stephanie Therese Chung · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
The Role of GPR120 and Omega-3 Fatty Acids in Steatosis and Systemic Inflammation
$55,670Sarah J Carlson · Boston Children'S Hospital · F32 · FY2013 · HD
A Role of Hypothalamic Dysfunction in Alcoholic Liver Disease
$55,616Christoph Buettner · Icahn School Of Medicine At Mount Sinai · R01 · FY2014 · AA
Transgenerational effects of endocrine disruptors: epigenetics and physiology
$55,545Marisa S. Bartolomei · University Of Pennsylvania · R01 · FY2016 · ES
Prevention of Ground Pad During Radiofrequency Tumor Ablation
$55,543Dieter Haemmerich · Medical University Of South Carolina · R01 · FY2010 · CA
MATERNAL DIET MODIFIES THE FETAL PRIMATE EPIGENOME AND CIRCADIAN GENE EXPRESSION
$55,512Kevin L Grove · Oregon Health & Science University · P51 · FY2008 · RR
Nested Study: Identifying Risk for Diabetes and Heart Disease in Women: A Study of African-American, African and White Federal Employees and Contractors
$55,373Stephanie Therese Chung · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
Cytokines in Pediatric Steatohepatitis
$55,352Children'S Memorial Hospital (Chicago) · F32 · FY2005 · HD
Functional role of Serum Amyloid A in periapical inflammation
$55,311Hajime Sasaki · Ada Forsyth Institute, Inc. · R01 · FY2017 · DE
LXR and human ApoE isoform effects on AD phenotype: in vitro and in vivo models
$55,295Radosveta P Koldamova · University Of Pittsburgh At Pittsburgh · R01 · FY2013 · AG
Nonalcoholic fatty liver disease, associated lipidomic changes, and preeclampsia risk
$55,208Tatyana Kushner · Icahn School Of Medicine At Mount Sinai · K23 · FY2024 · HL
STRUCTURAL BASIS FOR SCAP/SREBP INTERACTION
$55,094Joshua James Ziarek · Harvard Medical School · F32 · FY2014 · GM
Cell cycle regulators control adiposity and metabolism
$55,094Daniel Carl Berry · Ut Southwestern Medical Center · F32 · FY2014 · DK
The role of non-canonical IKKs in metabolic disease
$55,094Shannon Marie Reilly · University Of Michigan At Ann Arbor · F32 · FY2014 · DK
A Novel Therapeutic Approach to Combat Nonalcoholic Fatty Liver Disease
$55,094Kathleen Markan-Klostermann · University Of Iowa · F32 · FY2014 · DK